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Purpose/Objective: Pitch usually has little impact on the 
dose distribution for radiation of small spherical treatment 
volumes such as brain metastases or prostates. However, for 
geometrical reasons a pitch might be detrimental for patients 
with long treatment volumes, such as nasopharyngeal 
carcinoma (NPC) or esophageal cancer. During the course of 
radiotherapy patients with head and neck cancer may have 
rotational variations of up to 8° and esophageal cancer 
patients of up to 6° (Zhang L et al. Int J Radiat Oncol Biol 
Phys 2006, Chen YL et al. Int J Radiat Oncol Biol Phys 2007). 
The purpose of our study was to investigate if the dose 
distribution in the case of long treatment volumes is 
relevantly affected by the patient’s pitch and if a correction 
using a treatment couch with six degrees of freedom (6DoF) 
is necessary. 
Materials and Methods: 10 patients with NPC and 10 patients 
with esophageal cancer have been included in our planning 
study. All patients have been treated with volumetric 
modulated arc therapy (VMAT) with 66-70 Gy in 33-35 
fractions in the case of NPC and with 41.4-54 Gy in 23-28 
fractions in the case of esophageal cancer. Patient’s pitch 
was simulated by tilting the planning CT in ventral and dorsal 
direction by +/-1.5° and +/-3° around the middle of the dens 
axis for NPC volumes and the middle of the PTV for 
esophageal volumes. These rotational values were chosen, 
because most clinical treatment tables with 6 DoF are not 
able to adjust a tilt of more than 3°. A copy of the original 
CT dataset was made, identifying DICOM tags were deleted 
and PTV structures and structures of OARs were copied on 
the CT dataset. Verification plans were calculated on the 
four tilted datasets. PTV coverage and mean and maximum 
dose to the organs at risk (OARs) were compared to the 
original plan and to the dose constraints of the OARs. 
Results: For NPC patients the deviation in dose to the PTV is 
increasing with the degree of pitch but the effect appears to 
be relatively small with mean changes of up to 2%. For 
esophageal cancer pitches of 1.5° and 3° resulted in even 
less variation of dose to the PTV and PTV coverage with mean 
changes of up to 1%. The OARs that are most affected by a 
certain tilt of NPC patients are brainstem, spinal cord, 
lenses, oral mucosa and parotid glands (see Table 1). Brain, 
chiasm and optical nerves were stable in absolute dose. For 
esophageal cancer there was no significant change in dose to 
any OAR and none of the OARs exceeded the organ tolerance 
due to the pitch. However, in NPC patients 11/40 treatment 
plans would no longer be acceptable according to the dose 
constraints of the OARs with a pitch of +/-1.5° (N=1/N=2) and 
+/-3° (N=3/N=5). 
 
 
 
Conclusions: PTV coverage in both tumor entities was only 
slightly affected, but pitch error could be detrimental for 
OARs in NPC patients. Therefore a correction is 
recommended for NPC patients, even with a pitch mismatch 
of 1.5°. In the latter situation the use of a 6DoF table might 
be clinically relevant.  
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Purpose/Objective: Neoadjuvant chemoradiotherapy (CRT) 
decreases the local recurrence rate in patients with locally 
advanced rectal cancer. To enhance response, multiple 
centers are investigating the possibility of a boost dose to the 
gross tumor volume (GTV), either sequentially or 
simultaneously. Few data is available on GTV regression 
during CRT. We aim to determine the pattern in order to 
optimize timing of dose escalation on the GTV and assess 
possibilities for adaptive planning. 
Materials and Methods: MRI was obtained before, weekly 
during, and 4 and 7 weeks after a five-week course of 
concomitant CRT in seven patients with locally advanced 
rectal cancer (T3-4 and/or N1-2). A dose of 50 Gy was 
administered during CRT, combined with daily capecitabine. 
GTV was contoured on high resolution axial T2 images, aided 
by diffusion weighted imaging (DWI) and the apparent 
diffusion coefficient map (ADC). Planning target volumes 
(PTV) were created on each time point, with margins based 
on previous research: 10 mm anteroposteriorly, 6 mm 
laterally and 12 mm craniocaudally.  
Results: On the whole, 52 usable MRIs were acquired. GTV 
volume measured 63.3 cc (SD 20.5 cc) at baseline and PTV 
209 cc (SD 50 cc). In six patients, tumor shrinkage started in 
the first two weeks of CRT, amounting to an average 
reduction of 10% per week (fig. 1). The seventh patient 
showed no response during CRT and suffered local 
progression before planned surgery. 
Overall, mean GTV volume after CRT was 32.3 cc (± 9.3 cc), a 
reduction of 45.7 % (± 17.7 %, p=0.018). The PTV volume 
after CRT was reduced by 72 cc ± 31 cc (34 % ± 12 %, 
p=0.018). Further reduction occurred up to seven weeks post-
CRT, resulting in mean GTV volume of 22.3 cc (± 9.3 cc), 
showing a total reduction of 58.3% (± 30.0%, p=0.028) 
compared to baseline.  
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Conclusions: GTV shrinkage of rectal tumors treated with 
neoadjuvant chemoradiotherapy already occurs in the first 
two weeks of treatment and continues up to 7 weeks post-
treatment. The observed volume reduction during treatment 
suggests a benefit for a sequential boost on the remaining 
tumor after CRT or for volume adaptation in case of a 
simultaneous integrated boost.  
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Purpose/Objective: Advances in small animal radiotherapy 
enable the delivery of increasingly complex heterogeneous 
dose distributions on the millimeter scale, but methods to 
plan complicated small animal treatments remain in their 
infancy. A pre-clinical irradiation plan is usually created 
based on cone beam CT data with the animal in treatment 
position under anesthesia. Combined with demands on 
throughput, fast and easy treatment planning methods and 
algorithms are required. The purpose of this study is to 
develop an optimization model that determines beam-on 
times for a given beam configuration, and to assess the 
benefits of automated treatment planning for small animal 
radiotherapy. 
Materials and Methods: The applied model determines a 
Pareto-optimal solution based on user-provided weights for 
objectives. An interactive approach allows the user to select 
the plan that yields the most preferred trade-offs. Two cases 
based on cone beam CT data of a rat were used, and manual 
and model-based optimization results were compared using 
dose-volume metrics. The kidneys, spine and gastrointestinal 
tract (GI) were delineated as organs at risk (OARs) and a 
fictitious planning target volume (PTV) was created around 
the spine. In case 1, the left kidney was targeted as PTV with 
four 10x10 mm2 beams and for case 2, twelve 8x10 mm2 
beams were used to target the PTV around the spine. A PTV 
dose of 8 Gy was prescribed, with a mean dose between 8 
and 10 Gy as constraint. Differences between prescribed and 
planned PTV dose, as well as OAR doses were included in 
penalty objectives. The model was integrated in a research 
version of Monte Carlo based small animal treatment 
planning system SmART-Plan (v2.0 Precision X-ray). 
Results: Results show that manual and automated treatment 
planning yields plans of similar quality as shown in the figure 
and table. A similar amount of time was needed for manual 
and model-based optimization. In this period, manual 
optimization generates a single plan, while a set of Pareto-
optimal plans is created with automated optimization, 
allowing for a more substantiated choice on trade-offs. 
Automated optimization often uses fewer beams than manual 
optimized plans, therewith lowering treatment delivery time. 
Additional benefits of automated planning include a 
decreased dependence on the planning skills of the user 
(often absent in pre-clinical research), and the potential to 
improve treatment standardization among institutions. For 
more complex irradiations, manual planning becomes 
infeasible, making automation a necessity. 
 
Conclusions: Automation of treatment planning offers 
benefits to optimize plan quality in the short available time 
for treatment planning, to decrease dependence on user 
skills, to give more insight in trade-offs, and to improve 
standardization. The interactive Pareto-optimization 
framework was be able to produce plans of good quality, and 
allows for extension to full inverse treatment planning.  
 
